IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 21 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,147 | -63.2% | 15,927 | -40.4% | 0.00% | – |
| Q2 2023 | $79,144 | -0.3% | 26,738 | -6.7% | 0.00% | – |
| Q1 2023 | $79,366 | +54260.3% | 28,652 | +3.6% | 0.00% | – |
| Q4 2022 | $146 | -99.9% | 27,661 | +12.6% | 0.00% | – |
| Q3 2022 | $98,000 | +66.1% | 24,573 | +59.9% | 0.00% | – |
| Q2 2022 | $59,000 | -11.9% | 15,364 | +17.2% | 0.00% | – |
| Q1 2022 | $67,000 | -10.7% | 13,113 | +4.6% | 0.00% | – |
| Q2 2021 | $75,000 | – | 12,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 396,425 | $5,927,000 | 0.29% |
| Gradient Capital Advisors, LLC | 21,718 | $325,000 | 0.18% |
| Hillsdale Investment Management Inc. | 15,200 | $232,000 | 0.02% |
| Orion Portfolio Solutions, LLC | 15,821 | $237,000 | 0.01% |
| IFP Advisors, Inc | 1,960 | $30,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 300 | $4,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 7 | $0 | 0.00% |
| MORGAN STANLEY | 2,100 | $31,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 5,900 | $98,000 | 0.00% |